Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP

The firm is currently offering Lipitor lawsuit evaluations to those who have suffered from allegedly serious Lipitor side effects.


(PRWEB) May 09, 2013

For the first time in 55 years, spending on medications in the United States has dropped, in part because of patent expirations for popular drugs such as Lipitor.* The Rottenstein Law Group LLP, a Lipitor law firm, offers its opinion on what this means for those who seek to file Lipitor lawsuit because they suffered from Lipitor-induced diabetes.

Pfizer lost patent protection for Lipitor in 2011, which led to other manufacturers’ selling cheaper generic versions of the drug. Given the great number of Lipitor users, that switch to generic plays a large role in reduced spending, according to a May 9 Reuters report.

Read more:  Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP